Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dista, primarily known as Dista Products, was a prominent pharmaceutical subsidiary of Eli Lilly and Company based in the United Kingdom. The company gained global recognition as the marketing and manufacturing entity for the landmark antidepressant Prozac (fluoxetine), which revolutionized the treatment of psychiatric disorders. Beyond psychiatry, Dista was a major player in the antibiotics market, producing well-known brands such as Keflex (cephalexin) and Ilosone (erythromycin). The company's primary operations were centered in Speke, Liverpool, where it maintained large-scale manufacturing facilities for fermentation and chemical synthesis. Although the Dista brand has since been integrated into the global Eli Lilly corporate identity, its legacy remains significant in the history of psychopharmacology and anti-infective therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dista.